Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 3/2012

01-03-2012 | Original Paper

Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany

Authors: Katrin Hertrampf, Jörg Wiltfang, Alexander Katalinic, Olaf Timm, Hans-Jürgen Wenz

Published in: Journal of Cancer Research and Clinical Oncology | Issue 3/2012

Login to get access

Abstract

Purpose

Oral and pharyngeal cancer is the seventh leading tumour in Europe. In Germany, more than 10,000 new cancer cases are diagnosed each year. This population-based project evaluated the available data to develop a more detailed epidemiological profile of oral and pharyngeal cancer.

Methods

The data on incidence and mortality rates of the population-based Cancer Registry of Schleswig–Holstein were evaluated according to tumour sites, tumour stages and residential areas by age groups and gender from 2000 to 2006 and the tumour stages from 2000 to 2007.

Results

From 2000 to 2006, 3,127 new cases of oral and pharyngeal cancer (72% in men vs. 28% in women) were registered. About 50% of all cases, in men and women, were between 60 and 79 years. This detailed analysis of tumour sites and tumour stages showed interesting differences and revealed considerable variations. The highest incidence rates for both men and women were diagnosed in stage IV for older people, in women for oral cancer and men for pharyngeal cancer. The highest incidence and mortality trends were observed in urban areas.

Conclusions

Detailed population-based results described important variations with regard to tumour sites, stages and areas. These data play a central role as they provide the epidemiological profile of a tumour. This profile, together with possible targeted knowledge evaluations of the public and the health care providers involved, can be used as a prerequisite for health care activities and for the development of preventive strategies for targeted public awareness campaigns.
Literature
go back to reference Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R (2009) Comparative cancer survival information in Europe. Eur J Cancer 45:901–908PubMedCrossRef Berrino F, Verdecchia A, Lutz JM, Lombardo C, Micheli A, Capocaccia R (2009) Comparative cancer survival information in Europe. Eur J Cancer 45:901–908PubMedCrossRef
go back to reference Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194–200PubMedCrossRef Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194–200PubMedCrossRef
go back to reference Dalton SO, Schuz J, Engholm G, Johansen C, Kjaer SK, Steding-Jessen M et al (2008) Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: summary of findings. Eur J Cancer 44:2074–2085PubMedCrossRef Dalton SO, Schuz J, Engholm G, Johansen C, Kjaer SK, Steding-Jessen M et al (2008) Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994–2003: summary of findings. Eur J Cancer 44:2074–2085PubMedCrossRef
go back to reference de Camargo Cancela M, Chapuis F, Curado MP (2010) Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers. Cancer Epidemiol 34:501–506PubMedCrossRef de Camargo Cancela M, Chapuis F, Curado MP (2010) Abstracting stage in population-based cancer registries: the example of oral cavity and oropharynx cancers. Cancer Epidemiol 34:501–506PubMedCrossRef
go back to reference Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592PubMedCrossRef
go back to reference Guntinas-Lichius O, Wendt T, Buentzel J et al (2009) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136:55–63CrossRef Guntinas-Lichius O, Wendt T, Buentzel J et al (2009) Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database. J Cancer Res Clin Oncol 136:55–63CrossRef
go back to reference Hakulinen T, Tryggvadottir L, Gislum M et al (2010) Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49:561–577PubMedCrossRef Hakulinen T, Tryggvadottir L, Gislum M et al (2010) Trends in the survival of patients diagnosed with cancers of the lip, oral cavity, and pharynx in the Nordic countries 1964–2003 followed up to the end of 2006. Acta Oncol 49:561–577PubMedCrossRef
go back to reference Hassler S, Sjölander P, Gröneberg H, Johansson R, Damber L (2008) Cancer in the Sami population of Sweden in relation to lifestyle and genetic factors. Eur J Epidemiol 23:273–280PubMedCrossRef Hassler S, Sjölander P, Gröneberg H, Johansson R, Damber L (2008) Cancer in the Sami population of Sweden in relation to lifestyle and genetic factors. Eur J Epidemiol 23:273–280PubMedCrossRef
go back to reference Hertrampf K, Wenz HJ, Koller M, Wiltfang J (2011a) Public awareness about prevention and early detection of oral cancer: a population-based study in Northern Germany. J Craniomaxillofac Surg May 16 (Epub ahead of print) Hertrampf K, Wenz HJ, Koller M, Wiltfang J (2011a) Public awareness about prevention and early detection of oral cancer: a population-based study in Northern Germany. J Craniomaxillofac Surg May 16 (Epub ahead of print)
go back to reference Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz H-J (2011b) Recent trends in oral and oropharyngeal cancer in Northern Germany and a comparison with national and European data. Commun Dent Health (in press) Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz H-J (2011b) Recent trends in oral and oropharyngeal cancer in Northern Germany and a comparison with national and European data. Commun Dent Health (in press)
go back to reference Horowitz AM, Moon HS, Goodman HS, Yellowitz JA (1998) Maryland adults’ knowledge of oral cancer and having oral cancer examinations. J Public Health Dent 58:281–287PubMedCrossRef Horowitz AM, Moon HS, Goodman HS, Yellowitz JA (1998) Maryland adults’ knowledge of oral cancer and having oral cancer examinations. J Public Health Dent 58:281–287PubMedCrossRef
go back to reference Katalinic A, Kunze U, Schafer T (2003) Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149:1200–1206PubMedCrossRef Katalinic A, Kunze U, Schafer T (2003) Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149:1200–1206PubMedCrossRef
go back to reference La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E (1997) Epidemiology and prevention of oral cancer. Oral Oncol 33:302–312PubMedCrossRef La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E (1997) Epidemiology and prevention of oral cancer. Oral Oncol 33:302–312PubMedCrossRef
go back to reference Lehnert M, Eberle A, Hentschel S et al (2005) Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany—incidence, clinical parameters, variations in recording. Gesundheitswesen 67:729–735PubMedCrossRef Lehnert M, Eberle A, Hentschel S et al (2005) Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany—incidence, clinical parameters, variations in recording. Gesundheitswesen 67:729–735PubMedCrossRef
go back to reference Ligier K, Belot A, Launoy G et al (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010. Oral Oncol 47:302–307PubMedCrossRef Ligier K, Belot A, Launoy G et al (2011) Descriptive epidemiology of upper aerodigestive tract cancers in France: incidence over 1980–2005 and projection to 2010. Oral Oncol 47:302–307PubMedCrossRef
go back to reference O’Sullivan EM (2008) International variation in the incidence of oral and pharyngeal cancer. Community Dent Health 25:148–153PubMed O’Sullivan EM (2008) International variation in the incidence of oral and pharyngeal cancer. Community Dent Health 25:148–153PubMed
go back to reference Patton LL, Agans R, Elter JR, Southerland JH, Strauss RP, Kalsbeek WD (2004) Oral cancer knowledge and examination experiences among North Carolina adults. J Public Health Dent 64:173–180PubMedCrossRef Patton LL, Agans R, Elter JR, Southerland JH, Strauss RP, Kalsbeek WD (2004) Oral cancer knowledge and examination experiences among North Carolina adults. J Public Health Dent 64:173–180PubMedCrossRef
go back to reference Petersen PE (2009) Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol 45:454–460PubMedCrossRef Petersen PE (2009) Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol 45:454–460PubMedCrossRef
go back to reference Pritzkuleit R, Holzmann M, Raspe H, Katalinic A (2009) Krebs in Schleswig-Holstein. Band 7 Inzidenz und Mortalität im Jahr 2006. Schmidt- Römhild, Lübeck Pritzkuleit R, Holzmann M, Raspe H, Katalinic A (2009) Krebs in Schleswig-Holstein. Band 7 Inzidenz und Mortalität im Jahr 2006. Schmidt- Römhild, Lübeck
go back to reference Pulte D, Brenner H (2010) Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15:994–1001PubMedCrossRef Pulte D, Brenner H (2010) Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist 15:994–1001PubMedCrossRef
go back to reference Reichart PA (2001) Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Investig 5:207–213PubMedCrossRef Reichart PA (2001) Identification of risk groups for oral precancer and cancer and preventive measures. Clin Oral Investig 5:207–213PubMedCrossRef
go back to reference Robert Koch Institut GdeKiDeV (2010) Krebs in Deutschland 2005–2006, Häufigkeiten und Trends, 7th edn. Robert Koch Institut, Berlin Robert Koch Institut GdeKiDeV (2010) Krebs in Deutschland 2005–2006, Häufigkeiten und Trends, 7th edn. Robert Koch Institut, Berlin
go back to reference Sankaranarayanan R, Ramadas K, Thomas G et al (2005) Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 365:1927–1933PubMedCrossRef Sankaranarayanan R, Ramadas K, Thomas G et al (2005) Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 365:1927–1933PubMedCrossRef
go back to reference Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, Teronen O (2008) Survival after diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg 46:187–191PubMedCrossRef Sargeran K, Murtomaa H, Safavi SM, Vehkalahti MM, Teronen O (2008) Survival after diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg 46:187–191PubMedCrossRef
go back to reference Schmassmann A, Oldendorf M-G, Gebbers J-O (2009) Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 24:603–609PubMedCrossRef Schmassmann A, Oldendorf M-G, Gebbers J-O (2009) Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. Eur J Epidemiol 24:603–609PubMedCrossRef
go back to reference Seoane J, Pita-Fernandez S, Gomez I et al (2010) Proliferative activity and diagnostic delay in oral cancer. Head Neck 32:1377–1384PubMedCrossRef Seoane J, Pita-Fernandez S, Gomez I et al (2010) Proliferative activity and diagnostic delay in oral cancer. Head Neck 32:1377–1384PubMedCrossRef
go back to reference Tomar SL, Logan HL (2005) Florida adults’ oral cancer knowledge and examination experiences. J Public Health Dent 65:221–230PubMedCrossRef Tomar SL, Logan HL (2005) Florida adults’ oral cancer knowledge and examination experiences. J Public Health Dent 65:221–230PubMedCrossRef
go back to reference Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef
go back to reference Warnakulasuriya S (2010) Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 46:407–410PubMedCrossRef Warnakulasuriya S (2010) Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 46:407–410PubMedCrossRef
go back to reference Zini A, Czerninski R, Sgan-Cohen HD (2010) Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 39:299–305PubMedCrossRef Zini A, Czerninski R, Sgan-Cohen HD (2010) Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 39:299–305PubMedCrossRef
Metadata
Title
Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany
Authors
Katrin Hertrampf
Jörg Wiltfang
Alexander Katalinic
Olaf Timm
Hans-Jürgen Wenz
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 3/2012
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-011-1118-6

Other articles of this Issue 3/2012

Journal of Cancer Research and Clinical Oncology 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine